Ponsegromab

珀塞古单抗

Report date: 2026/05/21 20:00:22

Base Information

Drug NamePonsegromab
Drug Alias NamePF-06946860
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionGrowth/differentiation factor 15 inhibitors
TargetsGrowth/differentiation factor 15
Therapy Area/IndicationsFeeding and Eating DisordersAnorexiaFatigue +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[23] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer (China) Research And Development Co LtdPfizer IncPfizer Manufacturing Belgium Nv +[4] 
Inactive CompaniesN/A
Active IndicationsFeeding and Eating DisordersAnorexiaFatigue +[11] 
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A